DAPk1 inhibits NF-κB activation through TNF-α and INF-γ-induced apoptosis

Cellular Signalling

Volumn 24, Issue 7, 2012, Pages 1471-1477

  Yoo, Heon Jong ^a   Byun, Hyun Jung ^b   Kim, Boh Ram ^b   Lee, Ki Hwan ^a   Park, Sang Yoon ^b   Rho, Seung Bae ^b  

^a Chungnam National University College of Medicine   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

Apoptosis; Cell cycle; DAPk1; NF B activation; Ovarian carcinoma cells

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; DEATH ASSOCIATED PROTEIN KINASE; DEATH ASSOCIATED PROTEIN KINASE 1; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P16; PROTEIN P27; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER PATIENT; CARCINOMA CELL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT RESPONSE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON-GAMMA; NF-KAPPA B; OVARIAN NEOPLASMS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84859982175     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2012.03.010     Document Type: Article

References (57)

1. Levine B., Klionsky D.J. Developmental Cell 2004, 6:463-477.
2. Bialik S., Kimchi A. Annual Review of Biochemistry 2006, 75:189-210.
3. Kuo J.C., Wang W.J., Yao C.C., Wu P.R., Chen R.H. The Journal of Cell Biology 2006, 172:619-631.
4. Harrison B., Kraus M., Burch L., Stevens C., Craig A., Gordon-Weeks P., Hupp T.R. Journal of Biological Chemistry 2008, 283:9999-10014.
5. Sanchez-Cespedes M., Esteller M., Wu L., Nawroz-Danish H., Yoo G.H., Koch W.M., Jen J., Herman J.G., Sidransky D. Cancer Research 2000, 60:892-895.
6. Kim D.H., Nelson H.H., Wiencke J.K., Christiani D.C., Wain J.C., Mark E.J., Kelsey K.T. Oncogene 2001, 20:1765-1770.
7. Dansranjavin T., Möbius C., Tannapfel A., Bartels M., Wittekind C., Hauss J., Witzigmann H. Oncology Reports 2006, 15:1125-1131.
8. Michie A.M., McCaig A.M., Nakagawa R., Vukovic M. FEBS Journal 2010, 277:74-80.
9. Deiss L.P., Feinstein E., Berissi H., Cohen O., Kimchi A. Genes & Development 1995, 9:15-30.
10. Inbal B., Cohen O., Polak-Charcon S., Kopolovic J., Vadai E., Eisenbach L., Kimchi A. Nature 1997, 390:180-184.
11. Cohen O., Inbal B., Kissil J.L., Raveh T., Berssi H., Spivak-Kroizaman T., Feinstein E., Kimchi A. The Journal of Cell Biology 1999, 146(146):141-148.
12. Jang C.W., Chen C.H., Chen C.C., Chen J.Y., Su Y.H., Chen R.H. Nature Cell Biology 2002, 4:51-58.
13. Wang W.J., Kuo J.C., Yao C.C., Chen R.H. The Journal of Cell Biology 2002, 159:169-179.
14. Chen C.H., Wang W.J., Kuo J.C., Tsai H.C., Lin J.R., Chang Z.F., Chen R.H. EMBO Journal 2005, 24:294-304.
15. Liambi F., Lourenco F.C., Gozuacik D., Guix C., Pays L., Del Rio G., Kimchi A., Mehlen P. EMBO Journal 2005, 24:1192-1201.
16. Lee J.H., Rho S.B., Chun T. Biotechnology Letters 2005, 27:1011-1015.
17. Anjum R., Roux P.P., Ballif B.A., Gygi S.P., Blenis J. Current Biology 2005, 15:1762-1767.
18. Henshall D.C., Araki T., Schindler C.K., Shinoda S., Lan J.Q., Simon R.P. Journal of Neurochemistry 2003, 86:1260-1270.
19. Kang B.N., Ahmad A.S., Saleem S., Patterson R.L., Hester L., Doré S., Snyder S.H. Journal of Neuroscience 2010, 30:93-98.
20. van Rossum D.B., Patterson R.L., Cheung K.H., Barrow R.K., Syrovatkina V., Gessell G.S., Burkholder S.G., Watkins D.N., Foskett J.K., Snyder S.H. Journal of Biological Chemistry 2006, 281:37111-37116.
21. Nikolaidis N., Chalkia D., Watkins D.N., Barrow R.K., Snyder S.H., van Rossum D.B., Patterson R.L. PLoS One 2007, 2:e204.
22. Stark G.R., Kerr I.M., Williams B.R.G., Silverman R.H., Schreiber R.D. Annual Review of Biochemistry 1998, 67:227-264.
23. Chawla-Sarkar M., Lindner D.J., Liu Y.F., Williams B.R., Sen G.C., Silverman R.H., Borden E.C. Apoptosis 2003, 8:237-249.
24. Gattoni A., Parlato A., Vangieri B., Bresciani M., Derna R. Clinica Terapeutica 2006, 157:377-386.
25. Willimsky G., Czeh M., Loddenkemper C., Gellermann J., Schmidt K., Wust P., Stein H., Blankenstein T. The Journal of Experimental Medicine 2008, 205:1687-1700.
26. Shankaran V., Ikeda H., Bruce A.T., White M., Swanson P.E., Old L.J., Schreiber R.D. Nature 2001, 410:1107-1111.
27. Qin Z., Blankenstein T. Nature Immunology 2004, 5:3-4.
28. Szlosarek P.W., Charles K.A., Balkwill F.R. European Journal of Cancer 2006, 42:745-750.
29. Balkwill F.R. Nature Reviews. Cancer 2009, 9:361-371.
30. Pfeffer K. Cytokine & Growth Factor Reviews 2003, 14:185-191.
31. Anderson G., Nakada M.T., DeWitte M. Current Opinion in Pharmacology 2004, 4:314-320.
32. Zidi I., Mestiri S., Bartegi A., Amor N.B. Medical Oncology 2010, 27:185-198.
33. Hsu H., Xiong J., Geoddel D.V. Cell 1995, 81:495-504.
34. Hau H., Shu H.B., Pan M.G., Goeddel D.V. Cell 1996, 84:299-308.
35. Baldwin A.S. Annual Review of Immunology 1996, 14:649-683.
36. Li H., Lin X. Cytokine 2008, 41:1-8.
37. Baeuerle P.A., Henkel T. Annual Review of Immunology 1994, 12:141-179.
38. Wulczyn F.G., Krappmann D., Scheidereit C. Journal of Molecular Medicine 1996, 74:749-769.
39. Karin M. The Cancer Journal from Scientific American 1998, 4:S92-S99.
40. Ghosh S., Karin M. Cell 2002, 109:S81-S96.
41. Karin M., Lin A. Nature Immunology 2002, 3:221-227.
42. Karin M., Cao Y., Greten F.R., Li Z.W. Nature Reviews. Cancer 2002, 2:301-310.
43. Yang L., Cao Z., Yan H., Wood W.C. Cancer Research 2003, 63:6815-6824.
44. Lin M.T., Chang C.C., Chen S.T., Chang H.L., Su J.L., Chau Y.P., Kuo M.L. Journal of Biological Chemistry 2004, 279:24015-24023.
45. Burke F., Smith P.D., Crompton M.R., Upton C., Balkwill F. British Journal of Cancer 1999, 80:1236-1244.
46. Kim E.J., Lee J.M., Namkoong S.E., Um S.J., Park J.S. Journal of Cellular Biochemistry 2002, 85:369-380.
47. Wall L., Burke F., Barton C., Smyth J., Balkwill F. Clinical Cancer Research 2003, 9:2487-2496.
48. Wall L., Burke F., Smyth J.F., Balkwill F. Gynecologic Oncology 2003, 88:S149-S151.
49. Lejeune F.J., Ruegg C., Lienard D. Current Opinion in Immunology 1998, 10:573-580.
50. Egberts J.H., Cloosters V., Noack A., Schniewind B., Thon L., Klose S., Kettler B., von Forstner C., Kneitz C., Tepel J., Adam D., Wajant H., Kalthoff H., Trauzold A. Cancer Research 2008, 68:1443-1450.
51. Pilati P., Rossi C.R., Mocellin S. Frontiers in Bioscience 2008, 13:3181-3193.
52. Mocellin S., Pilati P., Nitti D. Current Pharmaceutical Design 2007, 13:537-551.
53. Yi T., Yi Z., Cho S.G., Luo J., Pandey M.K., Aggarwal B.B., Liu M. Cancer Research 2008, 68:1843-1850.
54. Zhang Y., Gavriil M., Lucas J., Mandiyan S., Follettie M., Diesl V., Sum F.W., Powell D., Haney S., Abraham R., Arndt K. Cancer Research 2008, 68:9519-9524.
55. Vila-del Sol V., Punzon C., Fresno M. Journal of Immunology 2008, 181:4461-4470.
56. Li C., Yang Z., Zhai C., Qiu W., Li D., Yi Z., Wang L., Tang J., Qian M., Luo J., Liu M. Molecular Cancer 2010, 9:73.
57. Chuang Y.T., Fang L.W., Lin-Feng M.H., Chen R.H., Lai M.Z. Journal of Immunology 2008, 180:3238-3249.